F 0656
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Develop and implement a complete care plan that meets all the resident's needs, with timetables and
actions that can be measured.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 4. Review of
Resident #7's medical record revealed an admission date of 02/26/22 with diagnoses including Crohn's
disease, mild cognitive impairment, venous insufficiency, hypertension, hyperlipidemia, and personal
history of other venous thrombosis and embolism.
Review of a quarterly MDS assessment dated [DATE] revealed Resident #7 had mild cognitive impairment
and received an anticoagulant.
Review of Resident #7's March 2024 physician's orders revealed an order dated 02/15/23 for Xarelto oral
tablet 20 mg daily for deep vein thrombosis (DVT).
Review of Resident #7's plan of care revealed no evidence Resident #7 received an anticoagulant.
Interview on 03/12/24 at 11:00 A.M. with the DON verified there was no care plan in place for Resident #7's
anticoagulant.
5. Review of Resident #37's medical record revealed an admission date of 11/20/22 with diagnoses
including hyperkalemia, obesity, moderate protein-calorie malnutrition, and cognitive communication deficit.
Review of Resident #37's annual MDS assessment dated [DATE] revealed Resident #37 had moderate
cognitive impairment and received antianxiety and antidepressant medications.
Review of Resident #37's current physician's orders revealed an order dated 03/27/23 for mirtazapine tablet
15 milligrams (mg) give one tablet by mouth at bedtime for increase appetite and an order dated 07/19/23
for Vistaril oral capsule 25 mg give one capsule by mouth every dayshift for anxiousness, give one dose 30
minutes before dressing change.
Review of Resident #37's plan of care revealed no evidence Resident #37 received antianxiety and
antidepressant medications.
Interview on 03/13/24 at 10:12 A.M. with the DON verified there was no care plan in place for Resident
#37's antianxiety and antidepressant medications.
6. Review of Resident #39's medical record revealed an admission date of 02/05/24 with diagnoses
including Alzheimer's disease, depression, cognitive communication deficit, chronic kidney disease, and
hypertension.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 11
Event ID:
365904
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365904
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/13/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Saint Joseph Care Center
2308 Reno Drive NE
Louisville, OH 44641
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Review of Resident #39's admission/5-day MDS assessment dated [DATE] revealed Resident #39 was
cognitively impaired and received antipsychotic, antianxiety, and antidepressant medications.
Review of Resident #39's current physician's orders revealed an order dated 02/05/24 for citalopram
hydrobromide oral tablet 10 mg give two tablet by mouth one time a day for depression; an order dated
02/05/24 for lorazepam oral tablet 0.5 mg give one tablet every four hours as needed for anxiety; an order
dated 02/05/24 for Risperdal oral tablet 0.5 mg give one tablet by mouth at bedtime due to psychosis; and
an order dated 02/18/24 for Ativan oral tablet 0.5 mg by mouth at bedtime for anxiety/agitation. Continued
review of Resident #39's plan of care revealed no evidence Resident #39 received antianxiety,
antipsychotic, and antidepressant medications.
Interview on 03/12/24 at 4:30 P.M. with the DON verified there was no care plan in place for Resident #39's
antianxiety, antipsychotic, and antidepressant medications.
Based on interview and record review the facility failed to initiate care plans for hospice care and
medication monitoring. This affected six residents (#7, #14, #17, #23, #37 and #39) out of 18 residents
reviewed for care planning. The facility census was 51.
Findings Include:
1. Review of the medical record for Resident #17 revealed an admission date of 05/30/2023. Diagnoses
included respiratory failure, chronic kidney disease, Multiple Sclerosis, and localized swelling.
Review of Resident #17's admission Minimum Data Set (MDS) assessment dated [DATE] revealed
Resident #17 was cognitively intact, was dependent for mobility, and received anticoagulant medication.
Review of Resident #17's March 2024 physician orders revealed an order dated 06/23/23 for Eliquis
(anticoagulant or blood thinning medication) with directions to give 2.5 milligrams (mg) by mouth two times
a day for blood clots.
Review of Resident #17's care plan dated 12/27/23 revealed no evidence that the resident was receiving
anticoagulant medication.
Interview on 03/11/24 at 4:34 P.M. the facility's Director of Nursing (DON) confirmed the facility had not
developed a care plan for the use of Resident #17's anticoagulant medication.
2. Review of the medical record for Resident #23 revealed an admission date of 09/18/20. Diagnoses
included Parkinson's disease, fibromyalgia, atrial fibrillation, and hypertension.
Review of Resident #23's quarterly MDS assessment dated [DATE] revealed the resident was moderately
impaired, had heart failure, and received anticoagulant medication.
Review of Resident #23's March 2024 physician orders revealed an order Eliquis Tablet 2.5 MG with
directions to give 0.5 tablet by mouth two times a day for atrial fibrillation.
Review of Resident #23's Care Plan dated 01/24/24 revealed no evidence that the resident was receiving
anticoagulant medication.
Interview on 03/11/24 at 4:34 P.M. the facility's DON confirmed the facility was not monitoring for
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365904
If continuation sheet
Page 2 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365904
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/13/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Saint Joseph Care Center
2308 Reno Drive NE
Louisville, OH 44641
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
side effects related to Resident #23's anticoagulant medication.
Level of Harm - Minimal harm
or potential for actual harm
3. Review of Resident #14's medical record revealed the resident was admitted to the facility on [DATE] with
diagnoses including acute chronic respiratory failure, upper respiratory failure, emphysema, chronic
obstructive pulmonary disease, anxiety, vertebra fracture, and dysphagia.
Residents Affected - Some
Review of Resident #14's physician orders dated 01/24/24 revealed admission to hospice services for
emphysema.
Review of Resident #14's care plan revealed no focus areas, goals, or interventions for the hospice care
and services.
On 03/12/24 at 12:44 P.M. an interview with MDS Licensed Practical Nurse #265 confirmed Resident #14's
care plan did not reflect the new hospice order. No goals or interventions were documented in the plan of
care.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365904
If continuation sheet
Page 3 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365904
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/13/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Saint Joseph Care Center
2308 Reno Drive NE
Louisville, OH 44641
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 3. Review of
Resident #7's medical record revealed an admission date of 02/26/22 with diagnoses including Crohn's
disease, mild cognitive impairment, venous insufficiency, hypertension, hyperlipidemia, and personal
history of other venous thrombosis and embolism.
Residents Affected - Some
Review of a quarterly MDS assessment dated [DATE] revealed Resident #7 had mild cognitive impairment
and received an anticoagulant.
Review of Resident #7's March 2024 physician's orders revealed an order dated 02/15/23 for Xarelto oral
tablet 20 mg daily for deep vein thrombosis (DVT). There was no order for staff to monitor for side effects of
this anticoagulant medication.
Continued review of Resident #7s medical record including Medication Administration Records (MARs),
Treatment Administration Records (TARs) and the plan of care revealed no evidence of monitoring for side
effects related to Resident #7s anticoagulant.
Interview on 03/12/24 at 7:55 A.M with Licensed Practical Nurse (LPN) #263 revealed for anticoagulants
she would monitor for bruising or bleeding. When asked where documentation was to be done for this
monitoring, LPN #263 acknowledged there was not an order on the TAR for staff to document this and was
unaware of any other location where this information could be documented.
Interview on 03/12/24 at 10:35 A.M. with LPN #266 revealed she would look for cuts and bruises and if a
resident was bleeding to get the bleeding under control for a resident receiving an anticoagulant. When
asked where monitoring documentation was placed, LPN #266 stated a progress note could be made but
there was not a routine location for the monitoring to be signed off, such as on the TAR.
Interview on 03/12/24 at 10:44 A.M. with State Tested Nursing Assistant (STNA) #270 revealed they had
some skin documentation in the point of care system and but nothing routine to prompt checking for
bruising and bleeding. STNA #270 showed the surveyor during the interview the point of care interface
which was the same for all residents for skin observation and staff could select scratch, discoloration, red
area, skin tear, open area, resident not available, and resident refuse. STNA #270 indicated if there was a
bruise they had to report this information to the nurse.
Interview on 03/12/24 at 11:00 A.M. with the DON verified there was no monitoring in place for Resident
#7's anticoagulant.
Review of the facility policy, Anticoagulation-Clinical Protocol, dated November 2018, revealed the staff and
physician will monitor for possible complications in individuals who are being anticoagulated and will
manage related problems. If an individual on anticoagulation therapy shows signs of excessive bruising,
hematuria, hemoptysis, or other evidence of bleeding the nurse will discuss the situation with the physician
before giving the next scheduled dose of anticoagulant.
Based on interview, record review, and policy review the facility failed to monitor residents using
anticoagulant medications. This affected three residents (#7, #17 and #23) out of seven residents reviewed
for medications. The facility census was 51.
Findings Include:
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365904
If continuation sheet
Page 4 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365904
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/13/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Saint Joseph Care Center
2308 Reno Drive NE
Louisville, OH 44641
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Level of Harm - Minimal harm
or potential for actual harm
1. Review of the medical record for Resident #17 revealed an admission date of 05/30/2023. Diagnoses
included respiratory failure, chronic kidney disease, Multiple Sclerosis, and localized swelling.
Review of Resident #17's admission Minimum Data Set assessment dated [DATE] revealed the resident
was cognitively intact, was dependent for mobility, and received anticoagulant medication.
Residents Affected - Some
Review of the Resident #17's March 2023 physician orders revealed an order dated 06/23/23 for Eliquis
(anticoagulant or blood thinning medication) with directions to give 2.5 milligrams (mg) by mouth two times
a day for blood clots. Continued review revealed the facility had no orders in place to monitor the resident
for side effects related to her high-risk medication.
Continued review of the resident medical record including Point of Care system for state tested nursing
aides and the residents care plan revealed the facility did not have any evidence of monitoring for the
resident's anticoagulant medication.
Interview on 03/11/24 at 4:34 P.M. the facility's Director of Nursing (DON) confirmed the facility was not
monitoring for side effects related to Resident #17's anticoagulant medication.
2. Review of the medical record for Resident #23 revealed an admission date of 09/18/20. Diagnoses
included Parkinson's disease, fibromyalgia, atrial fibrillation, and hypertension.
Review of Resident #23's quarterly MDS assessment dated [DATE] revealed the resident was moderately
impaired, had heart failure, and received anticoagulant medication.
Review of Resident #23's March 2024 physician orders revealed an order Eliquis Tablet (anticoagulant) 2.5
mg with directions to give 0.5 tablet by mouth two times a day for atrial fibrillation. Continued review
revealed the facility had no orders in place to monitor the resident for side effects related to her high-risk
medication.
Continued review of the resident medical record including Point of Care system for state tested nursing
aides and the residents care plan revealed the facility did not have any evidence of monitoring for the
resident's anticoagulant medication.
Interview on 03/11/24 at 4:34 P.M. the facility's DON confirmed the facility was not monitoring for side
effects related to Resident #23's anticoagulant medication.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365904
If continuation sheet
Page 5 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365904
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/13/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Saint Joseph Care Center
2308 Reno Drive NE
Louisville, OH 44641
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated,
prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic
medications are only used when the medication is necessary and PRN use is limited.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
record review, interview, and facility policy review the facility failed to ensure monitoring for medication
effects and potential adverse consequences was completed for residents who were receiving psychotropic
medications. This affected two residents (#37 and #39) out of five residents reviewed for unnecessary
medications. The facility census was 51 residents.
Findings Include:
1. Review of Resident #37's medical record revealed an admission date of 11/20/22 and diagnoses
including hyperkalemia, obesity, moderate protein-calorie malnutrition, and cognitive communication deficit.
Review of Resident #37's annual Minimum Data Set (MDS) 3.0 assessment dated [DATE] revealed
Resident #37 had moderate cognitive impairment and received antianxiety and antidepressant medications.
Review of Resident #37's current physician's orders revealed an order dated 03/27/23 for mirtazapine tablet
15 milligrams (mg) give one tablet by mouth at bedtime for increase appetite and an order dated 07/19/23
for Vistaril oral capsule 25 mg give one capsule by mouth every dayshift for anxiousness, give one dose 30
minutes before dressing change. There were no orders for staff to monitor for side effects for these
medications.
Continued review of Resident #37's medical record including Medication Administration Records (MARs),
Treatment Administration Records (TARs), and the plan of care revealed no evidence of monitoring for side
effects related to her antianxiety and antidepressant medications.
Interview on 03/13/24 at 10:12 A.M. with the Director of Nursing (DON) confirmed the lack of medication
monitoring relative to Resident #37's antianxiety and antidepressant medications.
2. Review of Resident #39's medical record revealed an admission date of 02/05/24 and diagnoses
including Alzheimer's disease, depression, cognitive communication deficit, chronic kidney disease, and
hypertension.
Review of Resident #39's admission/5-day MDS 3.0 assessment dated [DATE] revealed Resident #39 was
cognitively impaired and received antipsychotic, antianxiety, and antidepressant medications.
Review of Resident #39's current physician's orders revealed an order dated 02/05/24 for citalopram
hydrobromide oral tablet 10 mg give two tablet by mouth one time a day for depression; an order dated
02/05/24 for lorazepam oral tablet 0.5 mg give one tablet every four hours as needed for anxiety; an order
dated 02/05/24 for Risperdal oral tablet 0.5 mg give one tablet by mouth at bedtime due to psychosis; and
an order dated 02/18/24 for Ativan oral tablet 0.5 mg by mouth at bedtime for anxiety/agitation. There were
no orders for staff to monitor for side effects for these medications.
Continued review of Resident #39's medical record including MARs, TARs and the plan of care revealed no
evidence of monitoring for side effects related to her antianxiety, antipsychotic, and antidepressant
medications.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365904
If continuation sheet
Page 6 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365904
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/13/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Saint Joseph Care Center
2308 Reno Drive NE
Louisville, OH 44641
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Interview on 03/12/24 at 4:30 P.M. with the DON confirmed the lack of medication monitoring relative to
Resident #39's antianxiety, antipsychotic, and antidepressant medications.
Review of the facility policy, Psychotropic Medication Use, dated July 2022, revealed residents receiving
psychotropic medications are monitored for adverse consequences including anticholinergics effects,
cardiovascular effects, metabolic effects, neurologic effects, and psychosocial effects.
Event ID:
Facility ID:
365904
If continuation sheet
Page 7 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365904
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/13/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Saint Joseph Care Center
2308 Reno Drive NE
Louisville, OH 44641
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0812
Level of Harm - Minimal harm
or potential for actual harm
Procure food from sources approved or considered satisfactory and store, prepare, distribute and serve
food in accordance with professional standards.
Based on observation, interview, and policy review the facility failed to ensure foods were labeled, dated,
and discarded when expired. This had the potential to affect all 51 residents in the facility.
Residents Affected - Many
Findings Include:
Observation of the main kitchen and resident refrigerators on 03/10/24 starting at 8:59 A.M. with Dietary
Manager (DM) #235 revealed the following areas of concern:
•
In the dry storage area in the main kitchen, there was an expired case of tortillas dated December 2023.
•
In the juice and supplement cooler in the main kitchen, there were multiple containers of yogurt and juice
that were out of date.
•
On the Division One unit, there were two containers of takeout food without a date or name.
•
On the Rehab unit, there was takeout with Resident #26's name and a date of 02/22/24. There was also an
undated container of takeout with a resident name that was no longer in the facility as of 03/10/24.
Interviews with DM #235 verified the out-of-date foods at the time of observation. DM #235 stated resident
food was to have a date and resident name and was to be discarded three days after the date listed on the
item. DM #235 stated dietary staff would go through the refrigerators once a week to discard out-of-date
food but indicated this process was not documented anywhere.
Review of an undated policy and procedure manual revealed leftover food should be stored in covered
containers or wrapped carefully and securely and clearly labeled and dated before being refrigerated.
Leftover food must be used within seven days or discarded as per the 2022 Federal Food Code. All foods
should be covered, labeled, and dated. All foods will be checked to assure that foods will be consumed by
their use by dates or discarded.
Review of the policy, Food Brought in By Family/Visitors, revised March 2022, revealed food brought by
family/visitors that is left with the resident to consume later is labeled and stored in a manner that is clearly
distinguishable from facility-prepared food. Containers are labeled with the resident's name, the item, and
the use by date. Nursing staff will discard perishable foods on or before the use by date. The nursing or food
service staff will discard any foods prepared for the resident that show obvious signs of potential foodborne
danger (for example past due package dates).
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365904
If continuation sheet
Page 8 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365904
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/13/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Saint Joseph Care Center
2308 Reno Drive NE
Louisville, OH 44641
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Provide and implement an infection prevention and control program.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, record review, and policy reviewed the facility failed to ensure staff wore appropriate
Personal Protective Equipment (PPE) into Resident #36's Enhanced Barrier Precautions (EBP) room and
completed appropriate hand washing during incontinence care for Resident #36. This affected one resident
(#36) out of three residents reviewed for transmission-based precautions. This had the potential to affect all
ten residents (#5, #20, #36, #7, #37, #4, #9, #1, #103, and #29) on the 500-hall where Resident #36
resided. The facility census was 51.
Residents Affected - Some
Findings Include:
Review of the medical record for Resident #36 revealed an admission date of 02/05/24. Diagnoses included
hydronephrosis with renal and ureteral calculous obstruction, urinary tract infection, and Multiple Sclerosis.
Review of Resident #36's admission Minimum Data Set assessment dated [DATE] revealed the resident
was cognitively intact, required substantial maximum assistance for toileting.
Review of Resident #36 physician order dated 03/10/24 revealed an order for the resident to be on EBP
every shift for extended-spectrum beta-lactamases (ESBL) for urinary tract infection (UTI).
Observation on 03/12/24 at 1:32 P.M. revealed a sign on Resident #36's door indicating the resident was on
EBP with instructions that everyone must clean hands including before entering and when leaving the
room. Providers and staff must also wear gloves and a gown for the following high contact resident care
activities which include dressing, bathing, transferring, changing linens, providing hygiene, and changing
briefs, or assisting with toileting. At this time State Tested Nursing Aide (STNA) #283 and STNA # 271
walked into Resident #36's room without applying a gown. The staff members washed their hands,
gathered supplies, and applied gloves. STNA #283 transferred Resident #36 from her recliner chair to her
bed using a Hoyer (mechanical) lift. She then repositioned her on the bed. STNA #283 removed the
resident's pants and brief, she used a washcloth with water and soap to clean the resident's perineal area,
clean water, and a washcloth to rinse the area, and another clean washcloth to dry the area. STNA #283
and STNA #271 positioned the resident on her right side and cleansed her buttocks with soap and water,
rinsed with clean water, and then dried her buttocks with a clean washcloth. STNA #283 grabbed a bottle of
incontinence cream, squeezed it into her gloved hand and used her hand to apply the cream on the
resident's buttocks. She then moved the resident to her back and applied the remaining cream on the
resident's perineal area with the same gloved hand. She attached the brief, pulled up the resident's pants
and used the remote to transfer the resident back to her recliner before removing her gloves and washing
her hands. STNA #283 and STNA #271 completed the incontinence care without donning gowns as
indicated on the signage outside of the residents' rooms.
Interview on 03/12/24 at 1:45 P.M. STNA #283 revealed she did not complete any hand washing or change
her gloves from the start of Resident 36's incontinence care until the resident was seated back in her
recliner. She also stated she did not know that she was required to follow the sign on the outside of
Resident #36's door because she knew the resident did not have a clotridiodes difficile (C. Diff) infection.
Interview on 03/12/24 at 2:15 P.M. the Director of Nursing confirmed Resident #36 is on EBP and all staff
who were providing direct care were required to wear a gown and gloves.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365904
If continuation sheet
Page 9 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365904
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/13/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Saint Joseph Care Center
2308 Reno Drive NE
Louisville, OH 44641
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Review of the undated facility policy Hand Washing/Hand hygiene revealed indications for hand hygiene
included after contact with blood, body fluids, or contaminated surfaces, before moving from work on a
soiled body site to a clean body site on the same resident.
Review of the undated Enhanced Barrier Precautions policy revealed EBP is used as an infection
prevention and control intervention to reduce the spread of multi-drug residence organism's tor residents.
EBP employs targeted gown and glove use during high contact resident care activities when contact
precautions do not otherwise apply. Gloves and gowns are applied prior to performing the high contact
resident care activities. Examples of high contact resident care activities requiring the use of gown and
gloves for EBP include dressing, bathing, transferring, providing hygiene, changing briefs, or assisting with
toileting. EBP are indicated for resident infected or colonized with ESBL producing enterobacterales.
This deficiency is an example of continued noncompliance from the survey completed on 03/04/24.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365904
If continuation sheet
Page 10 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365904
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/13/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Saint Joseph Care Center
2308 Reno Drive NE
Louisville, OH 44641
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0881
Implement a program that monitors antibiotic use.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview, record review, and policy review the facility failed to obtain an ordered culture and
sensitivity prior to starting antibiotic therapy for Resident #23. This affected one resident (#23) out of five
residents reviewed for antibiotic stewardship. The facility census was 51.
Residents Affected - Few
Findings Include:
Review of the medical record for Resident #23 revealed an admission date of 09/18/20. Diagnoses include
Parkinson's disease, fibromyalgia, and hypertension.
Review of Resident #23's nursing note dated 12/12/23 at 9:46 A.M. revealed the physician saw the resident
on rounds. The resident complained of constipation and abdominal discomfort due to constipation. The
physician examined the resident's abdomen and bowel sounds. The resident complained of burning with
urination. A urinalysis, lab, and antibiotic were ordered.
Review of Resident #23's physician orders revealed an order dated 12/13/23 to straight catheter for
urinalysis and culture and sensitive for dysuria and abdominal discomfort. Also noted was an order on
12/13/23 for the resident to start Cefdinir 300 milligrams (mg) (an antibiotic) with directions to take the
medication two times a day for infection/dysuria until 12/29/23.
Review of Resident #23 Medication Administration Record revealed she received Cefdinir 300 mg from
12/13/23 through 12/29/23.
Review of Resident #23 December 2023 lab work revealed the facility did not obtain Resident #23's
ordered urinalysis with a culture and sensitivity.
Review of the facility Infection Screening Evaluation, dated 12/12/23, revealed the resident did not meet
McGeer's criteria for Urinary Tract Infection.
Interview on 03/12/24 at 9:40 A.M. the Director of Nursing confirmed the facility missed the order to
complete Resident #23's urinalysis with a culture and sensitivity. She stated the facility did not follow correct
antibiotic stewardship practices by administering Resident #23 Cefdinir 300 mg twice daily and she did not
meet McGeers criteria for a urinary tract infection.
Review of the facility policy, Surveillance for infections, revised 09/2017, revealed nursing staff will monitor
residents for signs and symptoms that may suggest infection. When an infection or colonization with
epidemiologically important organisms is suspected cultures may be sent, if appropriate, to contracted
laboratory for identification or confirmation. Cultures will be further screened for sensitive to antimicrobial
medications to help determine treatment options.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365904
If continuation sheet
Page 11 of 11